Bo Lak
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docet… Read more
Bo Lak (002760) - Total Liabilities
Latest total liabilities as of September 2025: ₩10.77 Billion KRW
Based on the latest financial reports, Bo Lak (002760) has total liabilities worth ₩10.77 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bo Lak - Total Liabilities Trend (2013–2024)
This chart illustrates how Bo Lak's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bo Lak Competitors by Total Liabilities
The table below lists competitors of Bo Lak ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Golden Eagle Energy Tbk
JK:SMMT
|
Indonesia | Rp917.15 Billion |
|
SMG European Recovery SPAC SE
XETRA:RCVR
|
Germany | €48.45 Million |
|
Evermore Chemical Industry Co Ltd
TW:1735
|
Taiwan | NT$1.65 Billion |
|
Wellbiotec Co. Ltd.
KO:010600
|
Korea | ₩11.76 Billion |
|
Romsdal Sparebank
OL:ROMSB
|
Norway | Nkr7.12 Billion |
|
Acrinova AB Series B
ST:ACRI-B
|
Sweden | Skr472.42 Million |
|
Caprice Resources Limited
F:C3F
|
Germany | €375.09K |
|
Panagene Inc
KQ:046210
|
Korea | ₩24.65 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Bo Lak's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bo Lak's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bo Lak (2013–2024)
The table below shows the annual total liabilities of Bo Lak from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩12.63 Billion | +38.06% |
| 2023-12-31 | ₩9.15 Billion | -26.97% |
| 2022-12-31 | ₩12.53 Billion | +16.28% |
| 2021-12-31 | ₩10.77 Billion | +6.60% |
| 2020-12-31 | ₩10.11 Billion | -13.39% |
| 2019-12-31 | ₩11.67 Billion | +22.17% |
| 2018-12-31 | ₩9.55 Billion | +10.95% |
| 2017-12-31 | ₩8.61 Billion | -17.14% |
| 2016-12-31 | ₩10.39 Billion | +9.15% |
| 2015-12-31 | ₩9.52 Billion | -8.14% |
| 2014-12-31 | ₩10.36 Billion | -0.71% |
| 2013-12-31 | ₩10.44 Billion | -- |